Premier (PINC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for December 6, 2024, will be held virtually to maximize shareholder participation and allow electronic voting and Q&A.
Shareholders will vote on electing two Class II Directors, ratifying Ernst & Young LLP as auditor for FY2025, and approving executive compensation on an advisory basis.
Board recommends voting FOR all proposals.
Voting matters and shareholder proposals
Election of two Class II Directors (Richard J. Statuto and Ellen C. Wolf) to serve until 2027.
Ratification of Ernst & Young LLP as independent auditor for FY2025.
Advisory approval of executive compensation for FY2024.
Shareholders may submit proposals for the 2025 meeting between August 8 and September 7, 2025, following specific bylaw requirements.
Board of directors and corporate governance
Board consists of nine directors, eight of whom are independent; directors serve staggered three-year terms.
Board diversity policy considers gender, ethnicity, age, and other characteristics; current board includes three women and one African American director.
Board committees: Audit and Compliance, Compensation, Nominating and Governance, Finance, and Member Agreement Review.
Annual board and committee self-assessments, director education, and stock ownership guidelines in place.
Latest events from Premier
- Q4 revenue up 3%, FY25 guidance targets $1.02B revenue, $1.28 EPS, excluding divestitures.PINC
Q4 202423 Jan 2026 - Q1 net income rose to $72.9M on $248.1M revenue, driven by a $57M legal settlement.PINC
Q1 202516 Jan 2026 - Technology-driven growth, new leadership, and capital returns support long-term value.PINC
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Q2 loss driven by $126.8M impairment; guidance reaffirmed, adjusted EPS outlook raised.PINC
Q2 20259 Jan 2026 - AI-driven supply chain and shared services are key to transformative savings and future growth.PINC
Leerink’s Global Healthcare Conference 202518 Dec 2025 - Definitive merger agreement for $28.25/share cash buyout, board-approved, pending shareholder vote.PINC
Proxy Filing1 Dec 2025 - Shareholders to vote on $28.25 per share all-cash merger, board unanimously recommends approval.PINC
Proxy Filing1 Dec 2025 - Shareholders to vote on a $28.25 per share all-cash merger, unanimously backed by the board.PINC
Proxy Filing1 Dec 2025 - Acquisition by Patient Square Capital will take the company private, pending approvals.PINC
Proxy Filing1 Dec 2025